Status:
COMPLETED
Feasibility of Bronchial Washing Fluid for Molecular Testing With Next Generation Sequencing in Lung Cancer
Lead Sponsor:
Pusan National University Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This is a single center, clinical trial evaluating the relevance of intratumoral washing for detection of generic alteration with Next Generation Sequencing.
Detailed Description
This is a prospective, single-arm, open-label study to assess evaluate the relevance of intratumoral washing by ultrathin bronchoscopy (outer diameter; 3mm) for detection of genetic alterations using ...
Eligibility Criteria
Inclusion
- Age ≥ 20 years
- Obtained written informed consent
- No contraindication to bronchoscopy
- Subjects suspected of having lung cancer on computed tomography or diagnosed with lung cancer by histology or cytology
- Subjects planning to undergo tissue or liquid biopsy for genetic alteration with Next Generation Sequencing
Exclusion
- Subjects who withdraw informed consent
- Subjects who are unable to undergo liquid biopsy (plasma) and tissue biopsy for genetic alteration with Next Generation Sequencing based on the investigator's judgement
- Subjects diagnosed with a cancer other than non-small cell lung cancer from the lung tissue lesion
- Subjects diagnosed with a benign lesion from the lung tissue lesion
Key Trial Info
Start Date :
November 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT06141005
Start Date
November 30 2023
End Date
December 31 2024
Last Update
August 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan National University hospital
Busan, South Korea, 49241